Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer

Tekijä Iwama, Eiji, Okamoto, Isamu, Harada, Taishi, Takayama, Koichi, Nakanishi, Yoichi
Julkaistu 2014

Highly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR

Tekijä Iwama, Eiji, Takayama, Koichi, Harada, Taishi, Okamoto, Isamu, Ookubo, Fumihiko, Kishimoto, Junji, Baba, Eishi, Oda, Yoshinao, Nakanishi, Yoichi
Julkaisussa Oncotarget (2015)

Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

Tekijä Li, Heyan, Takayama, Koichi, Wang, Shuo, Shiraishi, Yoshimasa, Gotanda, Keisuke, Harada, Taishi, Furuyama, Kazuto, Iwama, Eiji, Ieiri, Ichiro, Okamoto, Isamu, Nakanishi, Yoichi
Julkaisussa Cancer Chemother Pharmacol (2014)

Paired genetic analysis by next‐generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis

Tekijä Otsubo, Kohei, Iwama, Eiji, Ijichi, Kayo, Kubo, Naoki, Yoneshima, Yasuto, Inoue, Hiroyuki, Tanaka, Kentaro, Osoegawa, Atsushi, Tagawa, Tetsuzo, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Cancer Sci (2020)

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis

Tekijä Yoneshima, Yasuto, Iwama, Eiji, Matsumoto, Shingo, Matsubara, Taichi, Tagawa, Testuzo, Ota, Keiichi, Tanaka, Kentaro, Takenoyama, Mitsuhiro, Okamoto, Tatsuro, Goto, Koichi, Mori, Masaki, Okamoto, Isamu
Julkaisussa Sci Rep (2021)

Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease‐free survival in individuals with non‐small cell lung cancer

Tekijä Ando, Nobuhisa, Tanaka, Kentaro, Otsubo, Kohei, Toyokawa, Gouji, Ikematsu, Yuki, Ide, Maako, Yoneshima, Yasuto, Iwama, Eiji, Inoue, Hiroyuki, Ijichi, Kayo, Tagawa, Tetsuzo, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Thorac Cancer (2020)

Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR‐tyrosine kinase inhibitors

Tekijä Furuyama, Kazuto, Harada, Taishi, Iwama, Eiji, Shiraishi, Yoshimasa, Okamura, Kyoko, Ijichi, Kayo, Fujii, Akiko, Ota, Keiichi, Wang, Shuo, Li, Heyan, Takayama, Koichi, Giaccone, Giuseppe, Nakanishi, Yoichi
Julkaisussa Cancer Sci (2013)

PICT1 expression is a poor prognostic factor in non-small cell lung cancer

Tekijä Okamura, Kyoko, Takayama, Koichi, Kawahara, Kohichi, Harada, Taishi, Nishio, Miki, Otsubo, Kohei, Ijichi, Kayo, Kohno, Mikihiro, Iwama, Eiji, Fujii, Akiko, Ota, Keiichi, Koga, Takaomi, Okamoto, Tatsuro, Suzuki, Akira, Nakanishi, Yoichi
Julkaisussa Oncoscience (2014)

P24: The predictive role of the WHO histological classification in the treatment of advanced thymoma

Tekijä Tagawa, Tetsuzo, Okamoto, Tatsuro, Morodomi, Yosuke, Iwama, Eiji, Nakanishi, Yoichi, Shimamatsu, Shinichiro, Takenoyama, Mitsuhiro, Ichinose, Yukito, Yamaguchi, Masafumi, Seto, Takashi, Katsura, Masakazu, Takada, Kazuki, Suzuki, Yuzo, Fujishita, Takatoshi, Maehara, Yoshihiko
Julkaisussa J Thorac Dis (2015)

Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation

Tekijä Zhao, Xiaoliang, Kim, In‐Kyu, Kallakury, Bhaskar, Chahine, Joeffrey J., Iwama, Eiji, Pierobon, Mariaelena, Petricoin, Emanuel, McCutcheon, Justine N., Zhang, Yu‐Wen, Umemura, Shigeki, Chen, Vincent, Wang, Changli, Giaccone, Giuseppe
Julkaisussa Mol Oncol (2021)

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations...

Tekijä Tanaka, Kentaro, Nosaki, Kaname, Otsubo, Kohei, Azuma, Koichi, Sakata, Shinya, Ouchi, Hiroshi, Morinaga, Ryotaro, Wataya, Hiroshi, Fujii, Akiko, Nakagaki, Noriaki, Tsuruta, Nobuko, Takeshita, Masafumi, Iwama, Eiji, Harada, Taishi, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Oncotarget (2017)

Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generati...

Tekijä Iwama, Eiji, Sakai, Kazuko, Azuma, Koichi, Harada, Daijiro, Nosaki, Kaname, Hotta, Katsuyuki, Nishio, Makoto, Kurata, Takayasu, Fukuhara, Tatsuro, Akamatsu, Hiroaki, Goto, Koichi, Shimose, Takayuki, Kishimoto, Junji, Nakanishi, Yoichi, Nishio, Kazuto, Okamoto, Isamu
Julkaisussa Cancer Sci (2018)

Genetic Profiling of Non‐Small Cell Lung Cancer at Development of Resistance to First‐ or Second‐Generation EGFR‐TKIs by CAPP‐Seq Analysis of Circulating Tumor DNA

Tekijä Otsubo, Kohei, Sakai, Kazuko, Takeshita, Masafumi, Harada, Daijiro, Azuma, Koichi, Ota, Keiichi, Akamatsu, Hiroaki, Goto, Koichi, Horiike, Atsushi, Kurata, Takayasu, Nakagaki, Noriaki, Nosaki, Kaname, Iwama, Eiji, Nakanishi, Yoichi, Nishio, Kazuto, Okamoto, Isamu
Julkaisussa Oncologist (2019)

Heregulin expression and its clinical implication for patients with EGFR-mutant non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitors

Tekijä Yonesaka, Kimio, Iwama, Eiji, Hayashi, Hidetoshi, Suzuki, Shinichiro, Kato, Ryoji, Watanabe, Satomi, Takahama, Takayuki, Tanizaki, Junko, Tanaka, Kaoru, Takeda, Masayuki, Sakai, Kazuko, Azuma, Koichi, Chiba, Yasutaka, Atagi, Shinji, Nishio, Kazuto, Okamoto, Isamu, Nakagawa, Kazuhiko
Julkaisussa Sci Rep (2019)

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade

Tekijä Tanaka, Kentaro, Yanagihara, Toyoshi, Ikematsu, Yuki, Inoue, Hiroyuki, Ota, Keiichi, Kashiwagi, Eiji, Suzuki, Kunihiro, Hamada, Naoki, Takeuchi, Ario, Tatsugami, Katsunori, Eto, Masatoshi, Ijichi, Kayo, Oda, Yoshinao, Otsubo, Kohei, Yoneshima, Yasuto, Iwama, Eiji, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Oncotarget (2018)

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

Tekijä Inoue, Hiroyuki, Tsutsumi, Hirono, Tanaka, Kentaro, Iwama, Eiji, Shiraishi, Yoshimasa, Hirayama, Aiko, Nakanishi, Takayuki, Ando, Hiroyuki, Nakajima, Maako, Shinozaki, Seiji, Ogata, Hiroaki, Uryu, Kazuyasu, Okamura, Koji, Kimura, Shinichi, Ogawa, Tomohiro, Ota, Keiichi, Yoneshima, Yasuto, Hamada, Naoki, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Transl Lung Cancer Res (2021)

Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Gro...

Tekijä Iwama, Eiji, Goto, Yasushi, Murakami, Haruyasu, Tsumura, Shinsuke, Sakashita, Hiroyuki, Mori, Yoshiaki, Nakagaki, Noriaki, Fujita, Yuka, Seike, Masahiro, Bessho, Akihiro, Ono, Manabu, Nishitsuji, Masaru, Akamatsu, Hiroaki, Morinaga, Ryotaro, Akagi, Takanori, Shimose, Takayuki, Tokunaga, Shoji, Yamamoto, Nobuyuki, Nakanishi, Yoichi, Sugio, Kenji, Okamoto, Isamu
Julkaisussa Oncologist (2019)

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer

Tekijä Otsubo, Kohei, Nosaki, Kaname, Imamura, Chiyo K., Ogata, Hiroaki, Fujita, Akitaka, Sakata, Shinya, Hirai, Fumihiko, Toyokawa, Gouji, Iwama, Eiji, Harada, Taishi, Seto, Takashi, Takenoyama, Mitsuhiro, Ozeki, Takeshi, Mushiroda, Taisei, Inada, Mieko, Kishimoto, Junji, Tsuchihashi, Kenji, Suina, Kentaro, Nagano, Osamu, Saya, Hideyuki, Nakanishi, Yoichi, Okamoto, Isamu
Julkaisussa Cancer Sci (2017)